00000cmm a22000005i 4500 UP-99796217611000191 Buklod 20231016105724.0 m||||fo||d| |||||| cr cn ||||||aa 231016s2011 gw ||||fo||d| ||||||engdd 9783642141362 (eBook) 9783642141355 (Hardcover) 9783642267888 (Softcover) (iLib)UPD-00206905139 DLC DMLR rda eng RC 268.3 C34 2011eb Cancer immunology and immunotherapy [electronic resource] edited by Glenn Dranoff. Berlin, Heidelberg Springer Berlin Heidelberg 2011 online resource (xiv, 306 pages) illustrations text rdacontent computer rdamedia online resource rdacarrier Current tropics microbiology and immunology 0070-217X 344 Title from title screen (viewed October 16, 2023) Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control--Fridman, Wolf H.; Galon, Jérome; Dieu-Nosjean, Marie-Caroline et al. STAT3: A Target to Enhance Antitumor Immune Response--Lee, Heehyoung; Pal, Sumanta Kumar; Reckamp, Karen. Subversion and Coercion: The Art of Redirecting Tumor Immune Surveillance--Mumm, John B.; Oft, Martin--Biology and Clinical Observations of Regulatory T Cells in Cancer Immunology--Teng, Michele W. L.; Ritchie, David S.; Neeson, Paul--Concepts and Ways to Amplify the Antitumor Immune Response--Rubin, Bent; Gairin, Jean Edouard IP-based subscription, on campus only Access via Electronic Resources of the UPD University Library Website The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that usher in a new era of cancer immunotherapy. These first-in-class? treatments reflect the substantive progress that basic and translational scientists have made towards understanding the mechanisms underlying protective tumor immunity in cancer patients Immunotherapies were first explored at the turn of the twentieth century, but the crafting of potent treatments required more detailed knowledge of how the immune system responds to cancer. Advances in genetic, cellular, and biochemical technologies have begun to yield this critical information, focusing attention on immune recognition, regulation, and escape. Indeed, the dynamic interplay of these processes in the tumor microenvironment is now recognized to play a decisive role in determining disease outcome. This volume highlights the rapid progress and breadth of research in cancer immunology, and provides a framework for anticipating many more clinical successes in cancer immunotherapy Electronic reproduction New York SpringerLink c2011 Available via World Wide Web through SpringerLink Cancer Immunological aspects. Cancer Immunotherapy. Dranoff, Glenn editor. SpringerLink (Online service). Springer eBooK. Issues in children's and families' lives 1572-1981 no.2 http://link.springer.com/book/10.1007/978-3-642-14136-2 Available for University of the Philippines Diliman via SpringerLink. Click here to access FO UPD DMLR RC 268.3 C34 Electronic Resource